Challenger rejected Dai-ichi Life Holdings’ takeover proposal, prompting a reaction in the Sydney market. The revised proposal values the equity at A$8.17 billion, but represents a premium of only 2.1%.
Challenger, an Australian retirement-income provider, rejected a proposal from Japan’s Dai-ichi Life Holdings to make it a subsidiary, and its shares fell shortly after trading began. Under the revised proposal, Challenger’s equity is valued at A$8.17 billion, based on an offer of A$12.2 per share for the 79.5% not already owned.
Dai-ichi Life had already increased the terms of its proposal, offering A$12.2 per share compared with A$11.8 under the initial proposal. However, Challenger’s board determined that the offer did not appropriately reflect fair value. The transaction remained a non-binding, conditional proposal and did not proceed to the start of a formal negotiation process.
Selling prevailed in the market, with the share price falling as much as 2.7% before paring the decline over time. The shares ultimately closed at A$11.74, down 1.8% from the previous day and their lowest level in four weeks. The broader market fell 0.8%.
Cameron カーコ of Pitcher Partners Sydney said the board could justify seeking an increased premium and could demand better terms. Depending on future developments, fair value for shareholders could be reassessed.